| Dr Michelle Ann Kyriakos, MD | |
|
1375 Nw Kingston Ave, Bend, OR 97701-2242 | |
| (541) 383-5958 | |
| (541) 383-3016 |
| Full Name | Dr Michelle Ann Kyriakos |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 1375 Nw Kingston Ave, Bend, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033194204 | NPI | - | NPPES |
| 075056 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD19546 (Oregon) | Primary |
| Entity Name | Signify Health Medical Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750845863 PECOS PAC ID: 2163764424 Enrollment ID: O20191220002077 |
News Archive
An editorial challenges physicians and the U.S. healthcare system to reconsider the current "one size fits all" care for diverticulitis and to employ a precision medicine approach to determine which patients should be referred for colonoscopy.
Lupin Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
HairDX, developer of the first genetic test for predicting the risk of male and female pattern hair loss (Androgenetic Alopecia) today announced it is now able to provide doctors with an improved prediction by looking at genetic variants inherited from the mother combined with the risk for baldness attributed by the father.
A new Lancet Series explores the latest developments in the diagnosis, treatment and biology of cardiac arrhythmias, ahead of the American Heart Association's annual meeting taking place this year on Nov 3–7 in Los Angeles, CA, USA.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Ann Kyriakos, MD 1375 Nw Kingston Ave, Bend, OR 97701-2242 Ph: (541) 383-5958 | Dr Michelle Ann Kyriakos, MD 1375 Nw Kingston Ave, Bend, OR 97701-2242 Ph: (541) 383-5958 |
News Archive
An editorial challenges physicians and the U.S. healthcare system to reconsider the current "one size fits all" care for diverticulitis and to employ a precision medicine approach to determine which patients should be referred for colonoscopy.
Lupin Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base).
iBio, Inc. announced today that the U.S. Food and Drug Administration (FDA) accepted an Investigational New Drug (IND) application filed for a vaccine candidate made with the Company's proprietary transformative technology, the iBioLaunch technology platform. The candidate vaccine was manufactured by iBio's research collaborator, Fraunhofer Center for Molecular Biotechnology (FCMB), in its cGMP pilot manufacturing facility in Newark, Delaware.
HairDX, developer of the first genetic test for predicting the risk of male and female pattern hair loss (Androgenetic Alopecia) today announced it is now able to provide doctors with an improved prediction by looking at genetic variants inherited from the mother combined with the risk for baldness attributed by the father.
A new Lancet Series explores the latest developments in the diagnosis, treatment and biology of cardiac arrhythmias, ahead of the American Heart Association's annual meeting taking place this year on Nov 3–7 in Los Angeles, CA, USA.
› Verified 4 days ago
Wendy Yerington Dryden, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2577 Ne Courtney Dr Ste 100, Bend, OR 97701 Phone: 541-383-3005 Fax: 541-383-1883 | |
Lisa Kristine Mizeur, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-4800 Fax: 541-706-4806 | |
William B Wignall, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1247 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-318-4249 | |
Edward M Tarbet, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1501 Ne Medical Center Dr, Bend, OR 97701 Phone: 541-382-2811 Fax: 541-317-4588 | |
Michael R. Hudson, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2600 Ne Neff Rd, Bend, OR 97701 Phone: 541-706-3700 Fax: 541-706-3730 | |
Dr. Laura Kay Pennavaria, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 568 Ne Savannah Dr, Bend, OR 97701 Phone: 541-516-1705 Fax: 541-833-2619 |